Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1978801 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL5596274 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL1095723 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL4100169 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL133456 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL6021620 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL23038765 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL4635532 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL1095934 | 0.98 | DNM1 (0.45) | DNM1USP2HTTTSHRMEN1 | |
| Ethylene Glycol SCHEMBL15090416 | 0.94 | MEN1 (0.47) | DNM1USP2HTTTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12257335-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-25 | — | — | US | disclosed |
| US-12083212-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2024-09-10 | — | — | US | disclosed |
| CN-113710329-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-113164361-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-4200301-A1 | PHOSPHOLIPID COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2023-06-28 | — | — | EP | disclosed |
| WO-2022046631-A1 | PHOSPHOLIPID COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| CN-114026233-A | Lipid nanoparticles | 盖纳万科学有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-20220023189-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-01-27 | — | — | US | disclosed |
| EP-3873412-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-08 | — | — | EP | disclosed |
| CN-113164361-A | Personal care compositions | 高露洁-棕榄公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020117238-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-06-11 | — | — | WO | disclosed |
| US-20160009657-A1 | AMINE-CONTAINING LIPIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-01-14 | — | — | US | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
| EP-1980567-A1 | New disaccharide-based tensides and emulsifiers | Beiersdorf AG (DE) | 2008-10-15 | — | — | EP | disclosed |
| EP-1863825-A1 | NOVEL SURFACTANTS AND NOVEL EMULSIFIERS MADE FROM DISACCHARIDES | Beiersdorf Aktiengesellschaft (DE) | 2007-12-12 | — | — | EP | disclosed |
| WO-2006100091-A1 | NOVEL SURFACTANTS AND NOVEL EMULSIFIERS MADE FROM DISACCHARIDES | BEIERSDORF AG (DE) | 2006-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | DNM1 946/4885USP2 3620/4885HTT 1524/4885 |
| US-20160009657-A1 | AMINE-CONTAINING LIPIDS AND USES THEREOF | PHOSPHO1, CHMP4B, SGMS1 | DNM1 946/4885USP2 3620/4885HTT 1524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.